Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
Mark W. Tenforde, Wesley H. Self, Manjusha Gaglani, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 12, pp. 459-465
Open Access | Times Cited: 159

Showing 26-50 of 159 citing articles:

Association Between Vaccination Status and Outcomes in Patients Admitted to the ICU With COVID-19*
Sean van Diepen, Finlay A. McAlister, Luan Manh Chu, et al.
Critical Care Medicine (2023) Vol. 51, Iss. 9, pp. 1201-1209
Closed Access | Times Cited: 17
Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022
Robyn Mitchell, Joelle Cayen, Nisha Thampi, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e239050-e239050
Open Access | Times Cited: 16
Misleading Beyond Visual Tricks: How People Actually Lie with Charts
Maxim Lisnic, Cole Polychronis, Alexander Lex, et al.
(2023), pp. 1-21
Open Access | Times Cited: 16
Exploring COVID-19 Vaccine Attitudes among Racially and Ethnically Minoritized Communities: Community Partners’ and Residents’ Perspectives
Isabel Martinez Leal, Journa Njoh, Tzu-An Chen, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3372-3372
Open Access | Times Cited: 15
Immunogenicity, clinical efficacy and safety of additional second COVID‐19 booster vaccines against Omicron and its subvariants: A systematic review
Santenna Chenchula, Madhu Bhargavi Chandra, Madhu Babu Adusumilli, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 1
Closed Access | Times Cited: 6
Cost-effectiveness of nirmatrelvir/ritonavir for high-risk adult outpatients with COVID-19 in Japan
Takahito Mizuno, Yu Kondo, Mikiyasu Sakai, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 8, pp. 716-724
Closed Access | Times Cited: 5
Comparison of COVID-19 and Non-COVID-19 Tracheostomised Patients: Complications, Survival, and Mortality Risk Factors
Marta Mesalles-Ruíz, Maitane Alonso, Marc Cruellas, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 633-633
Open Access
Nanotechnology Assisted Strategies to Tackle COVID and Long-COVID
Keshaw Ram Aadil, Khushboo Bhange, Gita D. Mishra, et al.
BioNanoScience (2025) Vol. 15, Iss. 2
Closed Access
Effectiveness of mass vaccination for prevention of hospitalization, severe disease and death due to SARS-CoV-2 omicron Ba.2 variant; a case- population study
Hamid Reza Shamsollahi, Sobhan Younesian, Ali Nikfarjam, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42670-e42670
Open Access
Safety and Efficacy of Ephedrine Alkaloids-Free Ephedra Herb Extract (EFE) for Mild COVID-19: A Double-Blind, Placebo-Controlled, Randomized Comparative Trial
Hiroshi Odaguchi, Sumiko Hyuga, Mariko Sekine, et al.
Microorganisms (2025) Vol. 13, Iss. 3, pp. 641-641
Open Access
Probing the biophysical constraints of SARS-CoV-2 spike N-terminal domain using deep mutational scanning
Wenhao O. Ouyang, Timothy J.C. Tan, Ruipeng Lei, et al.
Science Advances (2022) Vol. 8, Iss. 47
Open Access | Times Cited: 26
Prevalence and Severity of Symptoms 3 Months After Infection With SARS-CoV-2 Compared to Test-Negative and Population Controls in the Netherlands
Tessa van der Maaden, Elizabeth N. Mutubuki, Siméon de Bruijn, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 9, pp. 1059-1067
Open Access | Times Cited: 24
Return on Investment of the COVID-19 Vaccination Campaign in New York City
Pratha Sah, Thomas N. Vilches, Seyed M. Moghadas, et al.
JAMA Network Open (2022) Vol. 5, Iss. 11, pp. e2243127-e2243127
Open Access | Times Cited: 23
Current Challenges With the Use of Test-Negative Designs for Modeling COVID-19 Vaccination and Outcomes
Xu Shi, Kendrick Qijun Li, Bhramar Mukherjee
American Journal of Epidemiology (2022) Vol. 192, Iss. 3, pp. 328-333
Open Access | Times Cited: 23
Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home Cohort
Katy Smoot, Jianbo Yang, Danyel H. Tacker, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2231334-e2231334
Open Access | Times Cited: 22
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
Alessandra Aiello, Andrea Coppola, Serena Ruggieri, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 94, Iss. 4, pp. 290-299
Open Access | Times Cited: 22
Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants: A population-based, matched cohort study

PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0282806-e0282806
Open Access | Times Cited: 15
Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis
Obaidur Rahman, Taro Kamigaki, Moe Moe Thandar, et al.
BMJ Open (2023) Vol. 13, Iss. 12, pp. e076892-e076892
Open Access | Times Cited: 14
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19—VISION Network, 10 States, June 2021–March 2023
Eric P. Griggs, Patrick K. Mitchell, Victoria Lazariu, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 2, pp. 338-348
Open Access | Times Cited: 13
Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?
Paskorn Sritipsukho, Thana Khawcharoenporn, Boonying Siribumrungwong, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Impact of COVID-19 on Patients Hospitalized with ST-Segment Elevation Myocardial Infarction in the United States during the Early Pandemic: An Analysis of Outcomes, Care Delivery, and Racial Disparities in Mortality
Harris Majeed, Karthik Gangu, Rahul Shekhar, et al.
Infectious Disease Reports (2023) Vol. 15, Iss. 1, pp. 55-65
Open Access | Times Cited: 10
Quantifying the Social Value of a Universal COVID-19 Vaccine and Incentivizing Its Development
Rachel Glennerster, Thomas J. Kelly, Claire McMahon, et al.
(2024)
Open Access | Times Cited: 3
Association between COVID-19 Booster Vaccination and COVID-19 Outcomes among U.S. Adults
Kimberly H. Nguyen, Cheyenne McChesney, Ruchi Patel, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 503-503
Open Access | Times Cited: 3
Prior COVID-19 Diagnosis, Severe Outcomes, and Long COVID among U.S. Adults, 2022
Kimberly H. Nguyen, Yingjun Bao, Siyu Chen, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 669-669
Open Access | Times Cited: 3
Cost effectiveness analysis comparing varying booster intervals of vaccination policies to address COVID-19 situation in Thailand, 2023
Chayanit Mahasing, Rapeepong Suphanchaimat, Pard Teekasap, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0310427-e0310427
Open Access | Times Cited: 3

Scroll to top